102 related articles for article (PubMed ID: 12795648)
1. Cyclooxygenase expression in splanchnic hyposensitivity to glypressin of bleeding portal hypertensive rats.
Huang HC; Wang SS; Chen YC; Lee FY; Chang FY; Lin HC; Hou MC; Chan CC; Chen CT; Wu SL; Lee SD
Eur J Clin Invest; 2003 Jun; 33(6):505-12. PubMed ID: 12795648
[TBL] [Abstract][Full Text] [Related]
2. Effects of prostacyclin inhibition on splanchnic hyposensitivity to glypressin in a hemorrhage-transfused rat model of portal hypertension.
Wang SS; Chu CJ; Lee FY; Wu SL; Lin HC; Chan CC; Chang FY; Lee SD
Scand J Gastroenterol; 2000 Apr; 35(4):426-32. PubMed ID: 10831268
[TBL] [Abstract][Full Text] [Related]
3. Chronic inhibition of nitric oxide ameliorates splanchnic hyposensitivity to glypressin in a hemorrhage-transfused rat model of portal hypertension.
Huang HC; Chu CJ; Lee FY; Chang FY; Wang SS; Lin HC; Hou MC; Chan CC; Wu SL; Chen CT; Lee SD
Scand J Gastroenterol; 2000 Dec; 35(12):1308-13. PubMed ID: 11199372
[TBL] [Abstract][Full Text] [Related]
4. Aminoguanidine ameliorates splanchnic hyposensitivity to glypressin in a haemorrhage-transfused rat model of portal hypertension.
Chu CJ; Lee FY; Wang SS; Chang FY; Lin HC; Hou MC; Wu SL; Tai CC; Chan CC; Lee SD
Clin Sci (Lond); 1998 Nov; 95(5):629-36. PubMed ID: 9791050
[TBL] [Abstract][Full Text] [Related]
5. Splanchnic hyposensitivity to glypressin in a haemorrhage/transfused rat model of portal hypertension: role of nitric oxide and bradykinin.
Chu CJ; Wu SL; Lee FY; Wang SS; Chang FY; Lin HC; Chan CC; Lee SD
Clin Sci (Lond); 2000 Dec; 99(6):475-82. PubMed ID: 11099389
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of prostacyclin by indomethacin ameliorates the splanchnic hyposensitivity to glypressin in haemorrhage-transfused common bile duct-ligated rats.
Lee FY; Chu CJ; Wang SS; Chang FY; Lin HC; Hou MC; Chan CC; Wu SL; Chen CT; Huang HC; Lee SD
Eur J Clin Invest; 2001 Feb; 31(2):145-53. PubMed ID: 11168453
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide synthase expression in the splanchnic hyposensitivity to glypressin of a hemorrhage-transfused rat model with portal hypertension.
Huang HC; Chen YC; Wang SS; Chan CC; Lee FY; Chang FY; Lin HC; Hou MC; Lu RH; Wu SL; Lee SD
J Chin Med Assoc; 2004 Jun; 67(6):268-74. PubMed ID: 15366403
[TBL] [Abstract][Full Text] [Related]
8. Splanchnic hyposensitivity to glypressin in a hemorrhage-transfused common bile duct-ligated rat model of portal hypertension: role of nitric oxide and bradykinin.
Chen CT; Chu CJ; Lee FY; Chang FY; Wang SS; Lin HC; Hou MC; Wu SL; Chan CC; Huang HC; Lee SD
Hepatogastroenterology; 2009; 56(94-95):1261-7. PubMed ID: 19950773
[TBL] [Abstract][Full Text] [Related]
9. Adrenal dysfunction in portal hypertensive rats with acute hemorrhage.
Lee FY; Wang SS; Tsai MH; Huang HC; Lin HC; Lee SD
PLoS One; 2014; 9(3):e92093. PubMed ID: 24633079
[TBL] [Abstract][Full Text] [Related]
10. Enhanced cyclooxygenase-1 expression within the superior mesenteric artery of portal hypertensive rats: role in the hyperdynamic circulation.
Hou MC; Cahill PA; Zhang S; Wang YN; Hendrickson RJ; Redmond EM; Sitzmann JV
Hepatology; 1998 Jan; 27(1):20-7. PubMed ID: 9425912
[TBL] [Abstract][Full Text] [Related]
11. Influence of nitric oxide synthase and cyclooxygenase blockade on expression of cyclooxygenase and hemodynamics in rats with portal hypertension.
Cao H; Xu J; Liu H; Meng FB; Qiu JF; Wu ZY
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):564-9. PubMed ID: 17085343
[TBL] [Abstract][Full Text] [Related]
12. Expression of cyclooxygenase in hyperdynamic portal hypertensive rats.
Cao H; Xu J; Hua R; Meng FB; Qiu JF; Wu ZY
Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):252-6. PubMed ID: 16698586
[TBL] [Abstract][Full Text] [Related]
13. Endothelial COX-1 and -2 differentially affect reactivity of MVB in portal hypertensive rats.
Potenza MA; Botrugno OA; De Salvia MA; Lerro G; Nacci C; Marasciulo FL; Andriantsitohaina R; Mitolo-Chieppa D
Am J Physiol Gastrointest Liver Physiol; 2002 Sep; 283(3):G587-94. PubMed ID: 12181171
[TBL] [Abstract][Full Text] [Related]
14. Neuropeptide Y restores non-receptor-mediated vasoconstrictive action in superior mesenteric arteries in portal hypertension.
Hartl J; Dietrich P; Moleda L; Müller-Schilling M; Wiest R
Liver Int; 2015 Dec; 35(12):2556-63. PubMed ID: 26010514
[TBL] [Abstract][Full Text] [Related]
15. Role of nitric oxide synthase and cyclooxygenase in hyperdynamic splanchnic circulation of portal hypertension.
Xu J; Cao H; Liu H; Wu ZY
Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):503-8. PubMed ID: 18842497
[TBL] [Abstract][Full Text] [Related]
16. Sorafenib attenuates the portal hypertensive syndrome in partial portal vein ligated rats.
Reiberger T; Angermayr B; Schwabl P; Rohr-Udilova N; Mitterhauser M; Gangl A; Peck-Radosavljevic M
J Hepatol; 2009 Nov; 51(5):865-73. PubMed ID: 19726100
[TBL] [Abstract][Full Text] [Related]
17. Effects of nitric oxide and cyclooxygenase inhibition on splanchnic hemodynamics in portal hypertension.
Wu Y; Burns RC; Sitzmann JV
Hepatology; 1993 Dec; 18(6):1416-21. PubMed ID: 8244267
[TBL] [Abstract][Full Text] [Related]
18. Effects of F-180, a new selective vasoconstrictor peptide, compared with terlipressin and vasopressin on systemic and splanchnic hemodynamics in a rat model of portal hypertension.
Bernadich C; Bandi JC; Melin P; Bosch J
Hepatology; 1998 Feb; 27(2):351-6. PubMed ID: 9462630
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of endothelin receptors in the vasculature of portal hypertensive rats: role in splanchnic hemodynamics.
Cahill PA; Hou MC; Hendrickson R; Wang YN; Zhang S; Redmond EM; Sitzman JV
Hepatology; 1998 Aug; 28(2):396-403. PubMed ID: 9696003
[TBL] [Abstract][Full Text] [Related]
20. Prostacyclin decreases splanchnic vascular contractility in cirrhotic rats.
Liu DJ; Chen W; Huo YM; Liu W; Zhang JF; Hua R; Sun YW
Hepatobiliary Pancreat Dis Int; 2014 Aug; 13(4):416-22. PubMed ID: 25100127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]